Trump Timeline ... Trumpocalypse

Regeneron Confirms that REGN-COV2 [Experimental] Antibody Cocktail Provided to President Trump Under Compassionate Use Request
https://investor.regeneron.com/static-files/fd58ba6a-f401-47b0-9d65-cfb01c313ec6

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today confirmed that, as announced by the White House Press Secretary, Regeneron provided a single 8 gram dose of REGNCOV2, a cocktail of two monoclonal antibodies, for use by President Trump. REGN-COV2 is an investigational COVID-19 therapy, which was provided in response to an Individual Patient Investigational New Drug (IND) application (commonly known as ‘compassionate use’ request) from the President’s physicians.

Regeneron has a compassionate use program with certain established criteria and review committee. As a matter of policy, the company does not disclose whether any individual has or has not submitted a request for compassionate use without their consent or prior disclosure.
 
Back
Top